Navigation Links
For the first time, researchers isolate adult stem cells from human intestinal tissue
Date:4/4/2013

CHAPEL HILL, N.C. For the first time, researchers at the University of North Carolina at Chapel Hill have isolated adult stem cells from human intestinal tissue.

The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology. It also enables them to explore new tactics to treat inflammatory bowel disease or to ameliorate the side effects of chemotherapy and radiation, which often damage the gut.

"Not having these cells to study has been a significant roadblock to research," said senior study author Scott T. Magness, PhD, assistant professor in the departments of medicine, biomedical engineering, and cell and molecular physiology at UNC. "Until now, we have not had the technology to isolate and study these stem cells now we have to tools to start solving many of these problems"

The UNC study, published online April 4, 2013, in the journal Stem Cells, represents a leap forward for a field that for many years has had to resort to conducting experiments in cells from mice. While significant progress has been made using mouse models, differences in stem cell biology between mice and humans have kept researchers from investigating new therapeutics for human afflictions.

"While the information we get from mice is good foundational mechanistic data to explain how this tissue works, there are some opportunities that we might not be able to pursue until we do similar experiments with human tissue," lead study co-author Adam D. Gracz, a graduate student in Magness' lab. Megan K. Fuller, MD, was also co-lead author of the study.

The Magness lab was the first in the United States to isolate and grow single intestinal stem cells from mice, so they had a leg up when it came to pursuing similar techniques in human tissue. Plus the researchers were able to get sections of human small intestine for their experiments that otherwise would have been discarded after gastric bypass surgery at UNC.

To develop their technique, the researchers investigated whether the approach they had taken in mice would work in human tissue. They first looked to see if the same molecules they had found stuck on the surface of mouse stem cells were also present on human stem cells. The researchers established that these specific molecules called CD24 and CD44 -- were indeed the same between the two species. They then attached fluorescent tags to these molecules and used a special machine called a fluorescence activated cell sorter to identify and isolate the stem cells from the small intestine samples.

They found that not only could they isolate the human stem cells from human intestinal tissue, but that they also could separate different types of intestinal stem cells from each other. These two types of stem cells active and reserve are a hot topic for stem cell researchers who are still trying to figure out how reserve stem cells cycle in to replenish active stem cells damaged by injury, chemotherapy or radiation.

"Now that we have been able to do this, the next step is to carefully characterize these populations to assess their potential," said Magness. "Can we expand these cells outside of the body to potentially provide a cell source for therapy? Can we use these for tissue engineering? Or to take it to the extreme, can we genetically modify these cells to cure inborn genetic disorders or inflammatory bowel disease? Those are some questions that we are going to explore in the future."


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina Health Care
Source:Eurekalert

Related medicine news :

1. Phase 1 ALS trial is first to test antisense treatment of neurodegenerative disease
2. The American Healthcare Documentation Professionals Group Launches Industry's First Complimentary Online HIPAA Training and Certification Program
3. Jessilyn Park Prepares For Her First Solo Art Show - "Illumination"
4. Researchers are first to use common virus to fortify adult stem cells
5. Celebrate National CPR/AED Week, American Heart Association CPR, BLS, ACLS, and Pediatric First-aid Courses are Now Offered Throughout the San Francisco Bay Area
6. Somax Power Hip Trainer First-Quarter Sales Double From Last Year
7. 5 from MD Anderson among first inaugurated to AACR Academy
8. Kettlebell Workouts Video Released By Geoff Neupert, StrongFirst Master Kettlebell Instructor, Explains the Benefits of Kettlbell Workouts
9. DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
10. CPR, BLS, ACLS, and Pediatric First-aid Courses Are Offered to the Public Throughout the San Francisco Bay Area: Learn 5 Reasons Why People Are Reluctant to Learn CPR.
11. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a ... mind and move the readers one step closer to God. “Psalms of Humidity” is ... his mistakes that have been made within his life are the very same things ...
(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring ... their closets. “They Sang At Her Funeral” is the creation of published author, Annalise ... five children and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to ...
(Date:9/19/2017)... ... 19, 2017 , ... Only a few physicians were selected to receive the ... A. Clevens, MD, FACS . The founder and medical director of Clevens Face ... trained at Yale, Harvard and the University of Michigan. He has served patients throughout ...
(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... Dallas, TX (PRWEB) , ... September 19, 2017 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – will return to Texas as a part of its national Swirl: ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... -- Xyntek Inc. has announced another milestone in their continued growth and success of ... growing demands of customer engagements regionally.  ... Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest ... In ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
Breaking Medicine Technology: